CEL-SCI Corp (CVM)
1.30
+0.04
(+3.17%)
USD |
NYAM |
May 21, 16:00
1.30
0.00 (0.00%)
After-Hours: 19:32
CEL-SCI Cash from Investing (Quarterly): 0.00 for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | -0.0649M |
September 30, 2023 | -0.0104M |
June 30, 2023 | -0.1969M |
March 31, 2023 | -0.1115M |
December 31, 2022 | -0.0536M |
September 30, 2022 | -0.0161M |
June 30, 2022 | -0.071M |
March 31, 2022 | -0.5338M |
December 31, 2021 | 6.112M |
September 30, 2021 | 4.590M |
June 30, 2021 | -2.000M |
March 31, 2021 | -14.62M |
December 31, 2020 | -3.150M |
September 30, 2020 | -1.125M |
June 30, 2020 | -0.8035M |
March 31, 2020 | -0.6571M |
December 31, 2019 | -0.1097M |
September 30, 2019 | -0.049M |
June 30, 2019 | -0.0582M |
March 31, 2019 | -0.1563M |
December 31, 2018 | -0.0723M |
September 30, 2018 | -0.0547M |
June 30, 2018 | -0.0023M |
March 31, 2018 | -0.0002M |
Date | Value |
---|---|
December 31, 2017 | -0.001M |
September 30, 2017 | -0.0065M |
June 30, 2017 | 0.00 |
March 31, 2017 | -0.0105M |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.0022M |
June 30, 2016 | -0.0148M |
March 31, 2016 | -0.0068M |
December 31, 2015 | -0.0148M |
September 30, 2015 | -0.0275M |
June 30, 2015 | -0.0076M |
March 31, 2015 | -0.0414M |
December 31, 2014 | -0.0171M |
September 30, 2014 | -0.0387M |
June 30, 2014 | -0.0476M |
March 31, 2014 | -0.044M |
December 31, 2013 | -0.0086M |
September 30, 2013 | -0.0149M |
June 30, 2013 | -0.0309M |
March 31, 2013 | -0.0708M |
December 31, 2012 | -0.0162M |
September 30, 2012 | -0.0114M |
June 30, 2012 | -0.0409M |
March 31, 2012 | -0.0645M |
December 31, 2011 | -0.0168M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-14.62M
Minimum
Mar 2021
6.112M
Maximum
Dec 2021
-0.6466M
Average
-0.0903M
Median
Cash from Investing (Quarterly) Benchmarks
AIM ImmunoTech Inc | -0.158M |
IGC Pharma Inc | -0.061M |
NovaBay Pharmaceuticals Inc | 1.068M |
Protalix BioTherapeutics Inc | -0.606M |
Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -4.528M |
Cash from Financing (Quarterly) | 6.596M |
Free Cash Flow | -20.40M |
Free Cash Flow Per Share (Quarterly) | -0.0871 |
Free Cash Flow Yield | -32.80% |